title: [Antihypertensive treatment compliance and obstacles to its improvement. Results of Russian program ARGUS-2].
abstract: OBJECTIVE
  To study barriers made by the patients for adequate treatment of arterial hypertension.
  
  
  METHODS
  The ARGUS-2 trial was made in 15 centers of 13 cities of Russia. Anonymous questionnaire survey covered 1298 patients (796 outpatients and 502 inpatients). The patients answered the following questions: 1) what are basic problems of life with hypertension; 2) compliance with intake of antihypertensive drugs; 3) causes of missed intakes of the drugs; 4) opposition to intake of drugs by the patients. Questioning procedure was preset by the trial protocol.
  
  
  RESULTS
  Only 37.4% (38.9% outpatients, 34.6% inpatients) were the treatment adopters. Drug intake was missed most frequently because offorgetting. The problems of life with hypertension were differently interpreted by patients and physicians: for the latter main problems were financial and routine while AH complications were on the 6-7 place. The latter were of primary importance for the patients while financial problems took place 4-6 Barriers to regular intake for the patients were poor self-control and unawareness about side effects of the drugs.
  
  
  CONCLUSIONS
  Complience of the patient can be improved only by complex approach: improvement of education, higher motivation, active involvement of patients into the treatment process, better contacts between the physician and the patient.
authors.forename: Zh D
authors.initials: ZhD
authors.lastname: Kobalova
authors.forename: E G
authors.initials: EG
authors.lastname: Starostina
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Kotovskaia
authors.forename: S V
authors.initials: SV
authors.lastname: Villeval'de
authors.forename: E I
authors.initials: EI
authors.lastname: Baranova
authors.forename: R S
authors.initials: RS
authors.lastname: Bogachev
authors.forename: N I
authors.initials: NI
authors.lastname: Volkova
authors.forename: S I
authors.initials: SI
authors.lastname: Drozdetskiĭ
authors.forename: O A
authors.initials: OA
authors.lastname: Kisliak
authors.forename: N A
authors.initials: NA
authors.lastname: Koziolova
authors.forename: I G
authors.initials: IG
authors.lastname: Kolina
authors.forename: Iu N
authors.initials: IuN
authors.lastname: Krasnova
authors.forename: Iu M
authors.initials: IuM
authors.lastname: Lopatin
authors.forename: V V
authors.initials: VV
authors.lastname: Maksimenko
authors.forename: S V
authors.initials: SV
authors.lastname: Negoda
authors.forename: E I
authors.initials: EI
authors.lastname: Tarlovskaia
authors.forename: L I
authors.initials: LI
authors.lastname: Tiukalova
authors.forename: R A
authors.initials: RA
authors.lastname: Khokhlov
authors.forename: M A
authors.initials: MA
authors.lastname: Freĭdlina
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000523:psychology; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance / Q000706:statistics & numerical data*; D010353:Patient Education as Topic; D010817:Physician-Patient Relations; D012189:Retrospective Studies; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D054928:Validation Studies as Topic
chemical_list: D000959:Antihypertensive Agents